BEIJING, Nov. 17, 2017 /PRNewswire/ -- Lianluo Smart Limited ("Lianluo Smart" or the "Company") (Nasdaq: LLIT), a
BDL primarily focuses on manufacturing traditional medical devices. The Company expects the sale price for BDL will be approximately RMB10 million. The transaction signifies Lianluo Smart's transformation to an asset-light smart medical device business from the asset-heavy traditional medical service business. Prior to selling BDL, the Company's sleep diagnosis and smart medical service related assets will be transferred to another of the Company's wholly-owned subsidiaries, Lianluo Connection Medical Wearable Device Technology (Beijing) Co., Ltd. ("LCL").á As part of the Company's strategy moving forward, LCL will concentrate on business development of the smart medical device market and acquisition of complementary smart medical devices and ecosystem platforms.
Mr. Ping Chen, CEO of Lianluo Smart stated, "We are pleased to announce this transaction as a significant step forward to complete our business transformation, as this sale also allows Lianluo Smart to be more focused on development and properly allocate our resources on its strengthŚsmart service and products. In addition, the transaction will significantly reduce the amortization of fixed assets and intangible assets, as well as the personnel and labor costs of related product lines. We remain focused on driving revenues from smart medical wearable devices and will keep our investors apprised of the progress of this transaction."
AboutáLianluo Smart Limited
Lianluo Smart Limited is a smart service and products provider, which develops, markets and sells medical wearable devices, intelligent smart devices and ecosystem platform ináChina. The medical wearable devices sector's major products are wearable sleep respiratory devices. It provides medical-grade detection and monitoring to OSA (Obstructive Sleep Apnea) syndrome patients. The smart devices sector is specialized in easy-using smart devices for sports, social contact, entertainment, remote-control and family health management. The smart ecosystem platform interconnects things and things, things and human. Lianluo Smart is endeavoring to become a leading provider of intelligent smart products both in domestic and international markets. More information may be found atáwww.lianluosmart.com.
AT THE COMPANY:Ms. Mary LiáTel: [email protected]
INVESTOR RELATIONS COUNSEL:The Equity Group Inc. Katherine Yao, Senior Associate Tel: [email protected]
View original content:http://www.prnewswire.com/news-releases/lianluo-smart-limited-announces-sale-of-wholly-owned-subsidiary-beijing-dehaier-medical-technology-co-ltd-300558466.html
SOURCE Lianluo Smart Limited
Subscribe to our Free Newsletters!
Sarcoma, is a cancer that may arise from several soft-tissues or bone. Treatment in early stages is ...
A wonder drug, soda bicarb or baking soda can be used for skin, teeth, hair, kidneys and much more ...
Melasma, also called as chloasma, is a skin hyperpigmentation problem characterized by brown spots ...View All